Zhaoyan new drug: gu Meifang, a shareholder, intends to reduce his stake in the company by no more than 0.6%.

[Zhaoyan New Drug: shareholder Gu Meifang plans to reduce no more than 0.6% of the company's shares]-- Zhaoyan New Drug announced that Gu Meifang, the company's shareholder, intends to reduce his holdings of no more than 3.22 million shares through bulk trading, that is, no more than 0.6011% of the company's current total share capital. Gu Meifang and his co-operative Gu Xiaolei hold a total of 5.5984% of the company.